Franklin Resources Portfolio holdings
Franklin Resources, Inc., commonly known as Franklin Templeton, was founded in 1947 by Rupert H. Johnson, Sr., and is headquartered in San Mateo, California, operating as a global investment management firm managing hundreds of billions in assets. The company offers a wide range of investment products, including mutual funds, ETFs, fixed-income portfolios, and alternative investments, serving individual investors, financial advisors, and institutions across over 150 countries. Known for its acquisition-driven growth—such as the 1992 purchase of Templeton Investments and the 2020 addition of Legg Mason—Franklin Templeton combines diverse strategies under a single brand, emphasizing both active management and income-focused solutions like its flagship Franklin Income Fund. With a reputation for adaptability and a client-centric approach, it remains a major player in the global asset management industry.
Top Buys
| 1 |
Blackrock
BLK
|
+$420M |
| 2 |
JPMorgan Chase
JPM
|
+$387M |
| 3 |
Parker-Hannifin
PH
|
+$324M |
| 4 |
Texas Instruments
TXN
|
+$310M |
| 5 |
Dominion Energy
D
|
+$263M |
Top Sells
| 1 |
Verizon
VZ
|
+$675M |
| 2 |
Merck
MRK
|
+$613M |
| 3 |
Southern Company
SO
|
+$518M |
| 4 |
Sempra
SRE
|
+$490M |
| 5 |
DTE Energy
DTE
|
+$477M |
Sector Composition
| 1 | Technology | 22.2% |
| 2 | Healthcare | 17.28% |
| 3 | Financials | 10.36% |
| 4 | Industrials | 9.21% |
| 5 | Consumer Discretionary | 8.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Ardelyx
ARDX
$1.58B
| $122K | ﹤0.01% |
206,332
-98,468
| -32% | -$58.2K |
|
2052
Caesarstone
CSTE
$48M
| $122K | ﹤0.01% |
13,336
-6,373
| -32% | -$58.3K |
|
2053
Frontline
FRO
$5.01B
| $122K | ﹤0.01% |
13,800
| – | – |
|
|
EQC
2054
DELISTED
Equity Commonwealth
EQC
| $120K | ﹤0.01% |
4,354
| – | – |
|
2055
ClearBridge Dividend Strategy ESG ETF
YLDE
$115M
| $119K | ﹤0.01% |
3,201
-141
| -4% | -$5.24K |
|
2056
Equinox Gold
EQX
$7.78B
| $118K | ﹤0.01% |
26,398
-472
| -2% | -$2.11K |
|
2057
InfuSystem Holdings
INFU
$213M
| $118K | ﹤0.01% |
12,279
-6,299
| -34% | -$60.5K |
|
2058
Sprinklr
CXM
$1.92B
| $116K | ﹤0.01% |
11,511
-3,533
| -23% | -$35.6K |
|
2059
Douglas Elliman
DOUG
$240M
| $116K | ﹤0.01% |
25,445
-11,598
| -31% | -$52.9K |
|
2060
Achieve Life Sciences
ACHV
$159M
| $115K | ﹤0.01% |
23,536
-10,431
| -31% | -$51K |
|
2061
BlackLine
BL
$3.38B
| $115K | ﹤0.01% |
1,722
-439
| -20% | -$29.3K |
|
2062
NextCure
NXTC
$13.6M
| $114K | ﹤0.01% |
2,024
-968
| -32% | -$54.5K |
|
|
VIRX
2063
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $114K | ﹤0.01% |
29,386
-14,232
| -33% | -$55.2K |
|
2064
Precision BioSciences
DTIL
$60M
| $113K | ﹤0.01% |
2,363
+1,516
| +179% | +$72.5K |
|
2065
NovaGold Resources
NG
$2.74B
| $113K | ﹤0.01% |
23,632
-828
| -3% | -$3.96K |
|
2066
Clearside Biomedical
CLSD
$26.6M
| $112K | ﹤0.01% |
76,041
-35,572
| -32% | -$52.4K |
|
2067
SPDR S&P Bank ETF
KBE
$1.55B
| $111K | ﹤0.01% |
+2,525
| New | +$111K |
|
2068
Aegon
AEG
$12B
| $110K | ﹤0.01% |
25,724
-5,126
| -17% | -$21.9K |
|
2069
ACV Auctions
ACVA
$1.89B
| $109K | ﹤0.01% |
16,607
-1,277
| -7% | -$8.38K |
|
|
LOGC
2070
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $109K | ﹤0.01% |
300,000
-613,576
| -67% | -$223K |
|
2071
BlackRock Resources & Commodities Strategy Trust
BCX
$787M
| $108K | ﹤0.01% |
+12,000
| New | +$108K |
|
|
ICPT
2072
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $108K | ﹤0.01% |
7,855
-3,345
| -30% | -$46K |
|
2073
DigitalBridge
DBRG
$2.05B
| $107K | ﹤0.01% |
5,475
-156
| -3% | -$3.05K |
|
2074
Franklin Emerging Market Core Dividend Tilt Index ETF
DIEM
$18.9M
| $106K | ﹤0.01% |
4,439
-101
| -2% | -$2.41K |
|
2075
iShares US Financials ETF
IYF
$4.03B
| $105K | ﹤0.01% |
1,500
| – | – |
|